Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 64 (RPL31P64)

Target
RPL31P64
Molecular classification
Other (pseudogene)
01

Overview

Ribosomal protein L31 pseudogene 64 (RPL31P64) is one of many genomic pseudogenes related to the ribosomal protein L31 gene (RPL31). Pseudogenes like RPL31P64 are DNA sequences that resemble protein-coding genes but are typically nonfunctional due to mutations that prevent translation or proper function. They are common for ribosomal protein genes, as these genes often have multiple processed pseudogenes dispersed throughout the genome[1][2][3][4]. Pseudogenes are generally not expressed as functional proteins and are not recognized as drug targets, biomarkers, or disease-associated genes. Key point: RPL31P64 is not a functional molecule or a therapeutic target. It is a non-coding pseudogene, and there are no known biological, pharmacological, or clinical roles associated with it[1][2][3][4]. If you intended to refer to the functional ribosomal protein, the canonical protein-coding gene is *RPL31* (ribosomal protein L31), but RPL31P64 specifically refers to a pseudogene, not the active protein[1][2][3][4].

Other names
RPL31P64ribosomal protein L31 pseudogene 64
02

Mechanism of action

None

03

Biological functions

None (pseudogenes do not encode functional proteins)
04

Disease associations

None established (no evidence for disease association)

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 64 (RPL31P64).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 64 (RPL31P64).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call